Cited by

• A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin.

  Yang X, Huang XJ, Chen Z, Xu AL, Zhou H, Bi XL, Yan PY, Xie Y. Yang X, et al. Heliyon. 2023 Feb 10;9(3):e13598. doi: 10.1016/j.heliyon.2023.e13598. eCollection 2023 Mar. Heliyon. 2023. PMID: 36895392 Free PMC article.
• The potential role of interleukin (IL)-25/IL-33/thymic stromal lymphopoietin (TSLP) on the pathogenesis of idiopathic pulmonary fibrosis.

  Xu X, Dai H, Zhang J. Xu X, et al. Clin Respir J. 2022 Nov;16(11):696-707. doi: 10.1111/crj.13541. Epub 2022 Sep 9. Clin Respir J. 2022. PMID: 36082495 Free PMC article. Review.
• Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.

  Martinez FJ, Yow E, Flaherty KR, Snyder LD, Durheim MT, Wisniewski SR, Sciurba FC, Raghu G, Brooks MM, Kim DY, Dilling DF, Criner GJ, Kim H, Belloli EA, Nambiar AM, Scholand MB, Anstrom KJ, Noth I; CleanUP-IPF Investigators of the Pulmonary Trials Cooperative. Martinez FJ, et al. JAMA. 2021 May 11;325(18):1841-1851. doi: 10.1001/jama.2021.4956. JAMA. 2021. PMID: 33974018 Free PMC article. Clinical Trial.
• Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials.

  van der Aar E, Desrivot J, Dupont S, Heckmann B, Fieuw A, Stutvoet S, Fagard L, Van de Wal K, Helmer E. van der Aar E, et al. J Clin Pharmacol. 2019 Oct;59(10):1366-1378. doi: 10.1002/jcph.1424. Epub 2019 Apr 23. J Clin Pharmacol. 2019. PMID: 31012984 Free PMC article. Clinical Trial.